Skip Navigation

Hepatocellular Carcinoma

printer friendly version


Early detection and prognosis of hepatocellular carcinoma

 

Enrollment status: Actively enrolling

 

Primary objective

To evaluate the usefulness of new markers found in blood that may help to diagnose hepatocellular carcinoma (HCC) early among people with cirrhosis. If we can establish new tumor markers for the detection of this tumor at early stage, which are currently lacking, this information could be applied to patients at the highest risk of HCC. We plan to store blood for this and future studies that may lead to better tests for the early detection of HCC.

Main inclusion criteria

Main exclusion criteria

Principal investigator

Contact persons


Improving measurement of longitudinal quality of life in patients with hepatocellular carcinoma

 

Enrollment status: Actively enrolling

 

Primary objective

To determine the feasibility of longitudinal quality of life measurement in patients diagnosed with hepatocellular carcinoma. We are assessing quality of life through serial surveys of patients diagnosed with HCC seen in our liver tumor clinics. We are performing assessment via a tablet or desktop computer at 0 days, 30 days, and 180 days with the primary objective of determining the feasibility of this approach. We also aim to determine the effects of treatment for HCC on quality of life.

Main exclusion criteria

Principal investigator

Contact person